Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
40679 Results Found
Blog: Irresponsible rhetoric should not drive public policy
The AHA has previously noted the third party observers who demonstrate a tenuous grasp of the data and rules regarding federal hospital transparency requirements.
Unwinding the Public Health Emergency Implications for Medicaid and CHIP and Mitigating Coverage Loss
The AHA has partnered with Manatt Health to develop a toolkit for hospitals and health systems to use as they work with the
AHA and AHIP File Joint Amicus Brief
Today, the American Hospital Association (AHA) and AHIP filed a joint amicus brief in United States v. Supervalu Inc. v. Safeway Inc. In the brief, the organizations argue that the federal government’s “erroneous construction and expansion of the FCA [False Claims Act] threatens the legitimate business activities of every government contractor, hospital, healthcare provider, health insurance provider, and grant recipient in the nation,” and would “ultimately divert resources away from the primary missions of AHA’s and AHIP’s members: caring for patients, reducing the cost of care, and ensuring a healthy citizenry.”
ASHE Recognized as ENERGY STAR Partner of the Year for Seventh Consecutive Year
CHICAGO – ASHE is proud to announce that it received the 2023 ENERGY STAR Partner of the Year—Sustained Excellence Award from the EPA.
Select Financial, Operating and Patient Characteristics of POHs Compared to Non-POHs Fact Sheet
Dobson | DaVanzo recently examined select operating, financial and patient characteristics of hospitals in categories defined by hospital ownership.1 This fact sheet provides descriptive statistics for physician owned hospitals (POHs) compared to non-physician owned hospitals.
4 Strategies to Drive Health-Equity Success
Innovative community-centered partnerships and creative investment strategies can mitigate health disparities that adversely affect excluded or marginalized groups. And many health systems are using these approaches to achieve powerful results, notes a recent NEJM Catalyst analysis.
Civica Rx Gets More Backing in Effort to Reduce Drug Prices and Shortages
The state of California put up $50 million to have Civica Rx manufacture and distribute low-cost biosimilars for the three most used short- and long-acting insulins.